Top Story

Children born to ovarian hyperstimulated women may have impaired cardiac function

November 28, 2014

The children of ovarian hyperstimulated mothers may be at increased risk of cardiovascular dysfunction, according to recent findings.

In the retrospective cohort study, researchers evaluated 42 healthy Chinese children born to women with ovarian hyperstimulation syndrome (OHSS). Thirty-four children were conceived through non-OHSS in vitro fertilization (IVF) and 48 were spontaneously conceived (SC); all were born between 2003 and 2007. Non-OHSS IVF and SC children were recruited from the same hospital and were matched for gestational age at delivery and birth weight. All children were aged 3 to 7 years.

Association News

American Thyroid Association elects board members

November 28, 2014
The American Thyroid Association installed new board members during its 84th annual meeting in Coronado, Calif.Robert C. Smallridge, MD, will serve as president…
Al Siu In the Journals

USPSTF finds insufficient evidence for universal vitamin D screening

November 26, 2014
The balance of benefits and harms of screening asymptomatic adults for vitamin D deficiency cannot be assessed based on existing evidence, according to a US Preventive…
Margaret A. Hamburg

FDA finalizes calorie information rules for menus, vending machines

November 26, 2014
The FDA finalized two rules requiring calorie information be clearly listed on menus and menu boards in chain restaurants, similar retail food establishments and vending…
Cora Peterson In the Journals

Preconception care for women with diabetes could save $5.5 billion

November 26, 2014
Health and cost burdens associated with pregestational diabetes could be prevented by universal preconception care, according to research published in the American
More News Headlines »
CME
Treatment of Acromegaly: Current Options - Part 3 of 5

Treatment of Acromegaly: Emerging Options - Part 4 of 5

This activity is supported by an educational grant from Genentech.

Several medical therapies for acromegaly, including somatostatin receptor agonists, dopamine receptor agonists, and a…
More »
Meeting News Coverage Video
thumbnail for video 3886443649001

Risk stratification guidelines help determine treatment for thyroid cancer

November 11, 2014
Fabian Pitoia, MD,  head of the thyroid section of the division of endocrinology at the Hospital de Clinicas of…
More »
CME
Acromegaly Cases

Acromegaly Cases: Expert Insights into Diagnosis and Emerging Treatment Options – Part 5 of 5

This activity is supported by an educational grant from Genentech.

Acromegaly is a rare chronic disorder that is typically caused by excessive growth hormone secretion, and is…
More »
morganatic-roan
morganatic-roan